Germany consults on new drug pricing mechanism
This article was originally published in Scrip
Germany's IQWiG, the Institute for Quality and Efficiency in Healthcare, now wants feedback on the results of a study of antidepressants trialling a pricing mechanism, the so called "efficiency frontier method", which could end up being used to determine drug prices after AMNOG pricing disagreements. According to the study, the mechanism has shown that prices of bupropion should be €2.93 rather than the current €104.88, IQWiG told Scrip.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.